〇Tatsunori Nishimura1, Natsuko Kimura2, Takahiko Murayama1, Yukino Machida2,3, Daisuke Iejima2, Reiko Sakamoto4, Mizuki Yamamoto5, Naoki Itano6, Yusuke Inoue7, Masataka Ito8, Nobuaki Yoshida4, Jun-ichiro Inoue5, Kouichi Akashi9, Hideyuki Saya10, Koji Fujita11, Masahiko Kuroda11, Issay Kitabayashi12, Arinobu Tojo2, Noriko Gotoh1
(1.Div. of Cancer Cell Biol., Cancer Res. Inst., Kanazawa Univ., 2.Div. of Mol. Therapy, Inst. of Med. Sci., Univ. of Tokyo, 3.Nip.Veter. and Life Sci. Univ., 4.Lab. of Dev. Genetics, Inst. of Med. Sci., Univ. of Tokyo, 5.Div. of Cellular and Mol. Bio., Inst. of Med. Sci., Univ. of Tokyo, 6.Dep. of Molecular Biosci., Faculty of Life Sci., Kyoto Sangyo University, , 7.Dep. of Diag. Radiol., Sch. of Med.,Kitasato Univ., 8.Dep. of Anat., National Def. Med. College, 9.Dep. of Medicine and Biosystemic Sci., Grad. Sch. of Med., Kyushu Univ., 10.Div. of Gene Regul., Insit. of Adv. Medical Res., Keio Univ., 11.Dep. of Mol. Path., Tokyo Medical Univ., 12.Div. of Hemat. Malignancy, Nat. Cancer Cent. Res. Inst.)
The 42nd Annual Meeting of the Molecular Biology Society of Japan
|Wed. Dec 4, 2019 9:58 AM - 10:23 AM